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The homeobox is a highly conserved 180-bp DNA sequence
encoding a 60-amino-acid motif termed homeodomain. The homeo-
domain acquires a helix—turn—helix structural conformation and is
the sequence-specific DNA-binding domain of a family of tran-
scriptional regulatory proteins (McGinnis et al, 1992). Genetic
studies have clearly shown that homeobox-containing genes play
fundamental developmental roles in determining the regionaliza-
tion of body parts (McGinnis et al, 1992), organogenesis (Roberts
et al, 1994), and the lineage of certain cell types (Li et al, 1990).
Human  CDX2 is a member of the caudal-related homeobox
family, based on its high level of amino acid similarity within the
homeodomain regions, and extensive conservation in the protein
sequence outside the homeodomain of the caudal gene of
Drosophila melanogaster (McGinnis et al, 1992). The caudal gene
is necessary for anteroposterior polarity during early Drosophila
development. Caudal-related genes of other species, including
mouse, are also expressed early in embryogenesis. In mouse, Cdx2
is expressed extraembryonically at 3.5 days post coitum (d.p.c.) in
the trophoectoderm, and later in some trophoectodermally derived
placental tissues. Embryonic expression begins at 8.5 d.p.c. in the
posterior gut, the tailbud, the posterior part of the neural tube, and
the unsegmented paraxial mesoderm before the development of
somites (Beck et al, 1995). In the later embryo and adult, Cdx2
expression is restricted to the intestinal epithelium, where tran-
script levels vary quantitatively along the rostrocaudal axis,
expression being highest in the proximal colon (James et al, 1994).
Importantly, Cdx2 protein expression is not confined to a partic-
ular cell lineage (James et al, 1994), suggesting that it may be
responsible for establishing regional, rather than cellular, identity
in the intestinal epithelium. Furthermore, as its expression is tissue
specific and present from the early embryo to the adult (James et
al, 1994), it is likely that Cdx2 plays a role in both the establish-
ment and maintenance of the intestinal epithelial phenotype.
Human  CDX2 has been localized to chromosome 13q12.3
(German et al, 1994). Cdx2 expression was examined in human and
rat colonic neoplasms, and was found to be decreased in colorectal
carcinomas (CRCs) (Ee et al, 1995; Mallo et al, 1997). In functional
studies, Cdx2 has been shown to be important in the regulation of
intestinal gene transcription (Suh et al, 1994), and in the regulation
of the differentiation and proliferation of intestinal cells (Suh et al,
1996). Heterozygous null mutant mice as to Cdx2 develop multiple
intestinal adenomatous polyps (Chawengsaksophak et al, 1997),
strengthening the possible relationship between Cdx2 and mainte-
nance of the intestinal phenotype. However, it is uncertain whether
or not the CDX2 gene is mutated in CRC. To address this question,
we searched for CDX2 gene alterations in sporadic and hereditary
non-polyposis colorectal cancer (HNPCC) CRCs.
MATERIALS AND METHODS
Subjects
A total of 49 tumours pathologically diagnosed as sporadic
advanced CRC, without polyposis or a family history of HNPCC,
and corresponding normal tissues were obtained by surgical or
endoscopical resection. Twenty-nine CRCs were also obtained
from Japanese patients that fulfilled the HNPCC criteria (Vasen et
al, 1991; Muta et al, 1996) by means of surgical resection. Previous
analysis of these samples demonstrated that 19 of them exhibited
the microsatellite instability (MSI) phenotype. Genomic DNA was
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extracted from frozen tissues or paraffin-embedded tissues as
described previously (Blin et al, 1976; Goelz et al, 1985).
Determination of the exon–intron organization
The genomic structure of CDX2 was determined through the
following steps. By comparing the mouse Cdx2 genomic DNA
(Genbank no. U00454) and human cDNA (Genbank no. Y13709)
sequences, and making use of the high homology between these
sequences, we could predict the possible splicing sites in the
human CDX2 genomic structure (Figure 1). Therefore, we
designed two primer sets (for intron 1: 5¢-gggctgctgcaaacgctcaacc-
3¢ and 5¢-actcgatatttgtctttcgtcctgg-3¢; and for intron 2: 5¢-
accaggacgaaagacaaatatcgag-3¢ and 5¢-acttctcagaggacctggctgag-3¢)
encompassing two candidate splicing sites from the human cDNA
sequence, and used the human genomic DNA as a template. In
addition, two other primer sets were used (primers 1U and 4D, and
primers 9U and 10D in Table 1) to ensure that there was no unex-
pected splicing site. The genomic fragments encoding the human
CDX2 gene were obtained by two methods. First, standard poly-
merase chain reaction (PCR) was performed for 30 cycles at 94°C
(1 min), 55—68°C (2 min), and 72°C (1 min), with a final 10-min
elongation at 72°C. Second, long and accurate (LA)-PCR was
performed when standard PCR failed to work. For this method, 30
cycles at 94°C (30 s) and 68°C (20 min), with final elongation at
72°C, were performed, using LA-Taq polymerase (Takara, Kyoto,
Japan). The PCR products were then purified using a QIA-quick
spin PCR purification kit (Qiagen, Chatsworth, CA, USA), and
then sequenced directly with a cycle sequencing kit (TaKaRa,
Kyoto, Japan) using end-labelled primers and the conditions spec-
ified by the manufacturer.
PCR amplification of CDX2 exons 1–3 and mutation
screening by PCR-SSCP (single-strand conformation
polymorphism)
According to the exon—intron boundary sequences we determined,
ten sets of overlapping primers numbered 1—10 (5¢ to 3¢) were
designed for all the three exons, including each splicing site of the
CDX2 gene (Figure 1, Table 1). Non-radioisotopic PCR-SSCP
analysis was performed as described previously (Oto et al, 1993).
Briefly, each PCR carried out comprised 30 cycles of denaturation
for 1 min at 94°C, annealing for 2 min at 55—64°C and extension
for 1 min at 72°C, followed by final extension for 10 min at 72°C.
Dimethyl sulphoxide was added for all PCR at 5% (v/v). The PCR
products and denaturing stop solution (95% formamide, 10 mM
EDTA, 0.25% bromophenol blue and xylene cyanol FF) were
heated at 80°C for 5 min and then cooled on ice rapidly, and then
electrophoresed on non-denaturing 12.5—15% polyacrylamide gels
containing 10% glycerol in Tris-glycine buffer (25 mM tris-HCl
and 200 mM glycine, pH 8.3) using a commercially available
minislab gel (90´70´1.0 mm) apparatus (Atto, Tokyo, Japan). The
running conditions were 320 V for 2—4 h at 15°C. After electro-
phoresis, the gels were stained with silver (Dai-ichi, Tokyo,
Japan). When abnormal patterns were observed on SSCP analysis,
the PCR products were cloned into the pT7Blue(R)T-vector
(Novagen, Madison, WI, USA) and sequenced as described above.
LOH (loss of heterozygosity) analysis
LOH was analysed by comparing normal and carcinoma DNA by
the PCR-SSCP method.
RESULTS
Structure of the CDX2 genomic locus
The genomic structure of CDX2 was determined as described in
the Materials and Methods section (Figure 1). The sequencing
revealed the sites and boundary sequences of each exon—intron
junction. The human CDX2 consists of three exons (541, 146 and
252 bp) separated by two introns of approximately 4.8 kb and 
1.4 kb. This structure is similar to the mouse Cdx2 gene (Genbank
no. U00454), except for the shorter introns in the mouse gene. The
primer set designed for each exon including exon—intron junctions
is listed in Table 1.
Mutations in CDX2
We did not observe any mutation in the entire CDX2 gene in the 49
sporadic CRC or ten HNPCC CRC without MSI on PCR-SSCP
analysis. Within the CDX2 coding region, there is a seven-guanine
repeat site eight codons away from the 3¢ terminus. Thus, we
further examined 19 HNPCC CRC exhibiting MSI in this region
using primer set 10, and observed one G insertion in carcinoma 841
(Figures 2A and B). The alteration was not found in the normal cell
DNA of this cancer patient, indicating a somatic mutation. This
insertion results in a frameshift with a new stop codon located 72
Table 1 The sequences of the primer sets for CDX2 exons 1–3
Primer Exon Primer sequenceb (5¢–3¢)T  ( °C)c Amplicon
seta (bp)
1 U 1 AGCATGGTGAGGTCTGCTCCd 62 161
D ACCGCCGTAGTCCGGGTACT
2 U 1 CAAGGACGTGAGCATGTACC 58 219
D GCGTAGCCATTCCAGTCCTC
3 U 1 ATCCTGGCCGGCAGCGTATG 60 168
D GGGTGGTGGTGCGGATGGTA
4 U 1 GGCCGCAGCCATGGGCTAC 62 172
D GGGAGACAGCTGCTCGGCG
5 U 1 TGCTGCAAACGCTCAACCCC 62 174
D ccttcccaagcaccctccga
6 U 2 ctgatgggctgccttgttgt 58 153
D CTCCGGATGGTGATGTAGC
7 U 2 CGGCTGGAGCTGGAGAAGG 64 148
D tggtcctctgccaggcagt
8 U 3 cacatcttcaccaccaccatgtgct 60 178
D GACCTGGCTGAGGCTGGGGA
9 U 3 AAAATCAACAAGAAGAAGTTGC 55 158
D GAGCCAGACACTGAGGCTT
10 U 3 GAAGTGTCCCAGAGCCCTTG 60 156
D TCAGCCTGGAATTGCTCTGCe
aU, sense primer; D, antisense primer. bUpper case letters correspond to
exons, and lower case ones to introns. cT, annealing temperature. dDesigned
according to untranslated sequences upstream of the initiating ATG.
eDesigned according to untranslated sequences downstream of the stop
codon.442 OK Yagi et al
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nucleotides downstream. As a result, the COOH-terminal eight
amino acids of CDX2 are substituted with 24 different amino acids,
some encoded by nucleotides normally in the 3¢ untranslated
region. We examined the entire CDX2 coding region in carcinoma
841, but we did not observe a second hit mutation.
Polymorphic sites and LOH analysis
The PCR-SSCP pattern of normal cell DNA showed five sequence
polymorphisms in primer sets 2, 5, 8—9 (overlapped), and 10 (two
loci) (Table 2). Therefore, LOH analysis was carried out on these
regions. The first variant, a CCG to CCC silent mutation, was
detected in exon 1 codon 61. Heterozygosity was seen in 9 of the
49 (18.4%) sporadic CRC cases, and in two of the ten (20%)
HNPCC cases without MSI. LOH was detected in two of the nine
(22.2%) sporadic CRC informative cases, but in none of the
HNPCC cases without MSI. Seven of the 48 (14.6%) healthy indi-
viduals examined exhibited such heterozygosity. The second
variant, an AAC to AAG transversion in codon 164 of exon 1,
changes asparagine to lysine. Only one of the 49 (2.0%) sporadic
carcinoma samples showed heterozygosity at this site, however it
did not exhibit LOH. Among the 48 healthy individuals examined,
we found one (2.1%) individual exhibiting the same pattern.
The third variant, a CCG to CTG transition in codon 260 of
exon 3, changes proline to leucine. This polymorphism was
located in an area in which primer sets 8 and 9 overlapped, and
therefore could be detected twice. Only 2 of the 49 (4.1%)
sporadic carcinoma cases were heterozygous for this area, and
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Figure 1 Structure of human CDX2. (A) A schematic diagram of the
organization of the human CDX2 cDNA (Genbank no. Y13709), and the
methods used for the isolation of genomic fragments. PCR, standard PCR;
LA-PCR, long and accurate PCR. Arrowheads indicate the predicted splicing
sites in the human CDX2 cDNA, in comparison with the highly homologous
mouse Cdx2 genomic DNA (Genbank no. U00454). Homeodomain (cross-
hatched region), a conserved sequence of 180 nucleotides shared by
members of the homeobox gene family. Hexapeptide (solid region), a
conserved hexapeptide motif upstream of the homeodomain, usually
separated from the homeodomain by an intron, characteristic of the caudal-
type homeobox genes (Suh et al, 1994). (B) Genomic structure of human
CDX2. Boxes, exons; exon numbers in boxes, the numbers of the 
exons;          , introns; kb, approximate lengths of the introns in kilobases; nt
numbers above the boxes, nucleotide numbers corresponding to the CDX2
cDNA sequence. The 5¢ boundary of exon 1 is defined by the ATG start
codon, and the 3¢ boundary of exon 3 by the TGA termination codon. Also
shown are the sites at which PCR products were generated by using the
primer sets listed in Table 1 for mutation screening
Table 2 Polymorphic sites and LOH of CDX 2 in sporadic and HNPCC CRC, and healthy individualsa
Codon 61 Codon 164 Codon 260 Codon 293
Sporadicb HNPCCc Healthyd Sporadic HNPCC Healthy Sporadic HNPCC Healthy Sporadic HNPCC Healthy
Homozygous Ae 39 (79.6) 8 (80) 41 (85.4) 48 (98.0) 10 (100) 47 (97.9) 47 (95.9) 10 (100) 47 (97.9) 34 (69.4) 9 (90) 31 (64.6)
Heterozygous 9 (18.4)g 2 (20) 7 (14.6) 1 (2.0) 0 (0) 1 (2.1) 2 (4.1) 0 (0) 1 (2.1) 12 (24.5)h 1 (10)i 16 (33.3)
Homozygous Bf 1 (2.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (6.1) 0 (0) 1 (2.1)
aOne healthy individual had a polymorphism in codon 310, an ACC to ACT silent mutation. bSporadic, sporadic CRC (n=49). cHNPCC, HNPCC cases without MI
(n=10). dHealthy, healthy individuals (n=48). eHomozygous A, G in codon 61, C in codons 164 and 260, and T in codon 293. fHomozygous B, C in codon 61, G
in codon 164, T in codon 260, and C in codon 293. gLOH found in two of the nine (22.2%) informative cases. hLOH found in 1 of the 12 (8.3%) informative
cases. It also exhibited LOH in codon 61. iLOH found in one of the one informative case.
841
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Figure 2 Mutation analysis of exon 3 of the CDX2 in HNPCC tumors. 
(A) SSCP analysis of the (G)7 repeat site by using primer set 10. The PCR
products were electrophoresed in a 12.5% polyacrylamide gel. Healthy
individual DNA (H) and normal tissue (N) both showed a normal SSCP
homozygous pattern. Mobility shifts were detected in carcinoma 841 (Ca), as
shown by arrowheads. (B) Sequencing analysis of the CDX2 (G)7 repeat in
carcinoma 841. The PCR products containing the (G)7 repeat site were
cloned into a pT7Blue(R)T vector as described in the text and then
sequenced. Mutant clones (MT) from carcinoma 841 showed eight guanines,
(G)8, at the repeat site, whereas the corresponding normal tissue was (G)7
wild-type (WT)CDX2 alterations in colorectal carcinomas 443
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neither of them exhibited LOH. One of the 48 (2.1%) healthy indi-
viduals was heterozygous. The fourth variant, a TCT to CCT tran-
sition in codon 293 of exon 3 (Figure 3), changes serine to proline,
and this heterozygous pattern was detected in 12 of the 49 (24.5%)
sporadic carcinoma cases and in 16 of the 48 (33.3%) healthy indi-
viduals. One of the 12 (8.3%) informative cases exhibited LOH,
and this was one of the two that exhibited LOH in codon 61.
Moreover, one of the ten HNPCC cases without MSI was
heterozygous and exhibited LOH at this site (Table 2). The fifth
variant is a silent ACC to ACT transition in codon 310 of exon 3,
which was detected in one of the healthy individuals. In carcinoma
841, the one exhibiting one G insertion at the (G)7 repeat site, a
second hit inactivation by LOH could not be determined because it
did not present any heterozygous pattern at these polymorphic
sites. Combining all the polymorphic sites in CDX2, we found two
LOH in a total of the 20 (10%) informative sporadic CRC and one
LOH in the three (33.3%) informative HNPCC cases.
DISCUSSION
Most sporadic CRC seem to undergo the traditional pathway of
tumorigenesis (Kinzler et al, 1996), in which one observes muta-
tions in APC for adenoma formation, K-ras for the adenomas to
become larger, and p53 for the carcinoma formation from these
adenomas. In HNPCC, a so-called mutator pathway has been
suggested, in which there is a germ-line mutation in one of the
mismatch repair genes and a second hit in the wild-type allele
would damage the DNA mismatch repair system (Hemminki et al,
1994). Through the resultant MSI phenotype, the transforming
growth factor b type II receptor gene (A)10 and apoptosis-related
BAX (G)8 repeat sites have been frequently found to be mutated in
HNPCC carcinomas (Markowitz et al, 1995; Rampino et al, 1997;
Yagi et al, 1998). Nevertheless, some types of CRC do not seem to
undergo any of these two pathways (Yagi et al, 1997).
Embryological studies have supported the hypothesis that the
Cdx2 expression is tissue specific and present from the early embryo
to the adult (James et al, 1994), therefore it is likely that Cdx2 plays
a role in both the establishment and maintenance of the intestinal
epithelial phenotype. Recently, the reduction in the mRNA and
protein expression in CRC (Ee et al, 1995; Mallo et al, 1997), and
the development of multiple intestinal adenomatous polyps in
heterozygous null mutant mice as to Cdx2 (Chawengsaksophak et
al, 1997) have strengthened the correlation of this gene and the
colorectal epithelium.
We analysed the entire coding region for CDX2 in 49 sporadic
advanced CRC and ten HNPCC cancers without MSI, but did not
observe any mutation. However, when we examined 19 cases of
HNPCC exhibiting MSI for a mutation in the seven-guanine repeat
site, we observed a G somatic insertion in one case (carcinoma
841), it becoming G7/G8 heterozygous. This insertion results in a
frameshift with a new stop codon located 16 amino acids down-
stream of the usual one. Carcinoma 841 belonged to a patient who
had two synchronous CRC located in the transverse and
descending colon respectively. In his family, there were eight
cases of carcinomas related to HNPCC, most of which were CRC.
We searched for second-hit inactivation of CDX2 in carcinoma
841, however, no alteration such as a second-hit mutation or LOH
was observed. Because no germ-line mutation was found in the
HNPCC cases examined, a CDX2 mutation may not be responsible
for familial predisposition to cancer in HNPCC.
We observed five sequence polymorphisms in codons 61, 164,
260, 293 and 310. We did not find any discrepancy in the propor-
tions of CDX2 homozygous and heterozygous cases in all-type
carcinomas compared with healthy individuals. For codon 61, two
of the nine (22.2%) informative sporadic CRC exhibited LOH. For
codon 293, 1 of the 12 (8.3%) informative sporadic carcinomas
exhibited LOH, and this carcinoma was one of the two that exhib-
ited LOH in codon 61 possibly indicating one whole CDX2 allele
deletion. For the remaining polymorphisms, there were only one
or two informative cases. Totally, LOH was observed in 2 of the 20
(10%) and in one of the three (33.3%) informative cases in
sporadic and HNPCC CRC respectively.
For codon 164, there was only one sporadic CRC case in which
the sequence changed from AAC to AAG. Among the 48 healthy
individuals examined, we observed such a pattern in one.
Therefore, we considered it a polymorphism. However, this C to G
transversion changes the predicted amino acid asparagine to
lysine, and this C nucleotide is right at the 5¢ extremity of the hexa-
peptide sequence which is a highly conserved domain and charac-
teristic of the caudal-related family (Suh et al, 1994). Such a
polymorphism might cause some change in the function of CDX2.
In conclusion, we found only one somatic mutation and three
cases of LOH in CDX2 in 78 CRC. Thus, we hypothesize that
genetic alterations in the CDX2 gene may play only a minor role in
sporadic and HNPCC colorectal carcinogenesis. As for the down-
regulation of the CDX2 mRNA and protein expression in CRC
observed previously, further investigations, such as analysis of its
regulatory mechanism, are necessary.
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